NCT01086423
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
- GSK Investigational Site Wuzhou, Guangxi, China
Clinical trial condition
Enterovirus Infections
Explore clinical trials studying Enterovirus Infections. Study availability and eligibility vary by location and protocol.
348 public trials
14 recruiting studies
Enterovirus Infections trial results
NCT00627458
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Jarvenpaa, Finland
- GSK Investigational Site Oulu, Finland
- GSK Investigational Site Pori, Finland
- GSK Investigational Site Tampere, Finland
NCT00635128
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
- GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
Completed
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Derval, France
- GSK Investigational Site La Chapelle-Basse-Mer, France
- GSK Investigational Site La Riche, France
- GSK Investigational Site Nantes, France
Completed
Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
NCT00871000
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Genoa, Liguria, Italy
- GSK Investigational Site Milan, Lombardy, Italy
- GSK Investigational Site Novara, Piedmont, Italy
- GSK Investigational Site Cagliari, Sardinia, Italy
NCT00325143
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
NCT00964028
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
NCT01086709
- Conditions
- Blood-Borne Infections, Cervical Neoplasia, Communicable Diseases, +23 more
- Locations
-
- Proyecto Epidemiologico Guanaste (PEG) San José, Costa Rica
NCT02815878
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +30 more
- Locations
-
- University of Washington Seattle, Washington, United States
Completed
IPV Clinical Trial - The Gambia
NCT01847872
- Conditions
- Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
- Locations
-
- Medical Research Council Unit Fajara, The Gambia